Inmunotek is a pharmaceutical company based in Alcalá de Henares – Madrid (Spain) that researches, develops, manufactures and markets products in the field of Allergy and Immunology for the diagnosis and treatment of allergic and other immune-based diseases in human and veterinary medicines.
Inmunotek was founded in 1992 by Dr. Jose Luis Subiza, board-certified immunologist, on the premises of a small clinical laboratory set in the 50′ by Dr. Eliseo Subiza (1921-1998), allergist and pioneer of palynology in Spain.
From the outset, our goal has been to offer innovative and competitive products of the highest quality, useful for professionals and safe and effective for the treatment of patients. To this end we have put together a highly professional and motivated team; we have outstanding facilities and a broad product porfolio.
Inmunotek facilities and manufacturing processes comply with GMPs. The products are approved by the Spanish Drug Agency and several international regulatory agencies, being marketed in more than 30 countries all over the world.
As a leading company in business growth, Inmunotek has been awarded as the “Best SME of the Year“ 2019 by CEPYME, granted with the IeE certificate for Excellence in Business Management and listed in the main rankings of fast growing companies in Europe (CEPYME500, FT1000, Inc5000).
Inmunotek has been awarded the National Innovation Award by the Ministry of Science and Innovation, which is the most important recognition in Spain in the field of innovation.